This brief explores key issues and poses questions regarding PEPFAR’s future, providing a roadmap for the major decisions ahead for the program. It identifies eight key, interrelated issues facing the administration, Congress, and other PEPFAR stakeholders.
- view as grid
- view as list
This post examines a growing COVID-19 vaccine gap in Red and Blue America, with the share of the population that have been fully vaccinated in counties that voted for President Biden in 2020 increasing more rapidly than the share in counties that voted for President Trump.
The U.S territories – American Samoa, the Commonwealth of the Northern Mariana Islands (CNMI), Guam, Puerto Rico, and the U.S. Virgin Islands (USVI) – have faced an array of longstanding fiscal and health challenges that were exacerbated by recent natural disasters and most recently by the COVID-19 pandemic. Differences in Medicaid financing, including a statutory cap and match rate, have contributed to broader fiscal and health systems challenges for the territories. Congress is currently debating legislation to address the looming Medicaid funding cliff. This brief builds on data in an earlier brief released in May 2021 examining the effects of the pandemic and the implications of the fiscal cliff and incorporates findings from a questionnaire sent to Medicaid Directors in territories in the summer of 2021.
Preventable Costs of Unvaccinated COVID-19 Patients Rise Sharply in August as Hospitalizations Surge
A surge in COVID-19 hospitalizations among people who have not been vaccinated in August is adding billions of dollars in preventable costs to the nation’s health-care system, an updated KFF analysis finds. In August, the new analysis estimates that the preventable costs of treating unvaccinated patients in hospitals total $3.7…
This updated analysis for the Peterson-KFF Health System Tracker estimates that the preventable costs of treating unvaccinated patients in hospitals total $3.7 billion in August, almost twice the estimates for June and July combined. The three-month total now stand at an estimated $5.7 billion.
Potential Savings for Medicare Part D Enrollees Under Proposals to Add a Hard Cap on Out-of-Pocket Spending
Medicare Part D, the outpatient prescription drug benefit for Medicare beneficiaries, provides coverage above a catastrophic threshold for high out-of-pocket drug costs, but there is no cap on total out-of-pocket drug costs that beneficiaries pay each year. Recent legislative proposals would add a cap on out-of-pocket spending under Part D. This analysis focuses on the potential impact of different out-of-pocket spending caps in terms of how many beneficiaries would be affected and how much they could save.
Understanding the Impact of Medicaid Premiums & Cost-Sharing: Updated Evidence from the Literature and Section 1115 Waivers
Our review of recent literature on premiums and cost-sharing is based on studies and reports published between 2017 and 2021. Our analysis of premiums in post-Affordable Care Act (ACA) Section 1115 waivers (approved under the Obama and Trump administrations) is based on available interim and final waiver evaluations as well as annual and quarterly state data reports posted on Medicaid.gov.
During the summer, the United States reported record extreme heat events across the country. While extreme heat and other hazardous weather events have implications for everyone, growing research shows that they disproportionately affect low-income people and people of color due to underlying social inequities and structural discrimination.
With the rapid uptake in vaccinations in recent months, COVID-19 deaths have fallen sharply. COVID-19 is now the seventh leading cause of death in the U.S. This updated analysis looks at the pandemic’s effect on mortality rates.
This new analysis examines the experiences of LGBT adults from the July COVID-19 Vaccine Monitor and finds that as a group they are more likely to be vaccinated for COVID-19 and less likely to view getting the vaccine as a health risk compared to non-LGBT adults. A larger share of LGBT adults than non-LGBT adults say they have received at least one dose of a COVID-19 vaccine (82% vs 66%) and are more supportive of vaccine mandates than non-LGBT adults.